Try adjusting your type
14th October, 2009
European Survey on Standards of Care in paediatric oncology centres. J. R. Kowalczyk, M. Samardakiewicz, K. Pritchard-Jones, R. Ladenstein, S. Essiaf, E. Fitzgerald, G. Petrarulo, G. Vassal - EJC , Volume 61, pp 11-19
8th December, 2014
The purpose of this website is to provide good and clear information about the long-term effects of childhood cancer and to refer to the various late-effects outpatient clinics (LATER outpatient clinics) that exist in the Netherlands.
8th September, 2015
Cancer in young people is rare, but it is still a major health issue in Europe. Each year, more than 6,000 young people in Europe die of cancer. There are more than 300,000 European childhood cancer survivors (in 2020, they will be nearly half a million): two-thirds of them have some late side effects of treatment, that are severe and impact on the daily life of half of those affected.
Stimulating development of more and better paediatric cancer drugs will be key to making progress, particularly in some of the hardest-to-treat childhood cancers.
Gilles Vassal, past-President of the European Society for Paediatric Oncology, outlines emerging strategies to make this happen.
Share it
18th July, 2023
We invite you to be part of our thriving online community, an interactive hub designed exclusively for young adults aged 10 to 39 who have bravely battled cancer. Here, you’ll discover a safe and inclusive space to connect with others who truly understand what you’ve been through.
8th August, 2022
Survey among clinicians and academics from across Europe to investigate the impact of the GDPR on childhood cancer research and to identify the challenges and opportunities in this field.
14th April, 2023
The Dutch Childhood Cancer Survivor Study (DCCSS-LATER) is a big study of the late effects of childhood cancer. On this site you find information about the various studies which are part of DCCSS-LATER.
Comments
Thank you. Comment sent for approval.
Something is wrong, try again later